Your browser doesn't support javascript.
loading
Rituximab maintenance significantly prolongs progression-free survival of patients with newly diagnosed mantle cell lymphoma treated with the Nordic MCL2 protocol and autologous stem cell transplantation.
Klener, Pavel; Salek, David; Pytlik, Robert; Mocikova, Heidi; Forsterova, Kristina; Blahovcova, Petra; Campr, Vit; Prochazka, Vit; Obr, Ales; Jaksa, Radek; Kuntscherova, Jana; Boudová, Ludmila; Kodet, Roman; Janikova, Andrea; Trneny, Marek.
Afiliação
  • Klener P; First Medical Department, Charles University General Hospital, Prague, Czech Republic.
  • Salek D; Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Pytlik R; Department of Hematology and Oncology, Masaryk University Hospital, Brno, Czech Republic.
  • Mocikova H; First Medical Department, Charles University General Hospital, Prague, Czech Republic.
  • Forsterova K; Department of Internal Medicine and Haematology, Faculty Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University, Prague, Czech Republic.
  • Blahovcova P; First Medical Department, Charles University General Hospital, Prague, Czech Republic.
  • Campr V; First Medical Department, Charles University General Hospital, Prague, Czech Republic.
  • Prochazka V; Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University Hospital, Motol, Czech Republic.
  • Obr A; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic.
  • Jaksa R; Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Olomouc, Czech Republic.
  • Kuntscherova J; Institute of Pathology, Charles University General Hospital, Prague, Czech Republic.
  • Boudová L; Department of Pathology, Charles University Medical Faculty Plzen, Prague, Czech Republic.
  • Kodet R; Department of Pathology, Charles University Medical Faculty Plzen, Prague, Czech Republic.
  • Janikova A; Department of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University Hospital, Motol, Czech Republic.
  • Trneny M; Department of Hematology and Oncology, Masaryk University Hospital, Brno, Czech Republic.
Am J Hematol ; 94(2): E50-E53, 2019 02.
Article em En | MEDLINE | ID: mdl-30474171
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Célula do Manto / Rituximab Tipo de estudo: Diagnostic_studies / Guideline Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma de Célula do Manto / Rituximab Tipo de estudo: Diagnostic_studies / Guideline Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article